Drug Safety and Availability > Updated: FDA Issues Second Warning to Physicians about Certain Compounded Drugs from Franck's

FDA has received additional reports of fungal endophthalmitis (eye infections) in patients who were given Brilliant Blue G (BBG) during eye surgery since the FDA Warning to Physicians was posted on March 19, 2012. The agency has also recently received reports of eye infections in patients who were given injections of drug products containing triamcinolone during eye surgery.

These drugs were supplied by Franck’s Pharmacy in Ocala, Florida. Brilliant Blue G is not an approved drug in the United States. Franck’s has recalled all lots of BBG and one lot of Triamcinolone Acetonide P.F. The Centers for Disease Control and Prevention (CDC) has advised healthcare personnel to stop use of all sterile triamcinolone-containing products purchased from Franck’s until further information regarding the safety of these products is available.

Clinicians in several states reported the adverse events.  FDA, CDC, and local and state public health agencies are actively investigating these incidents.

FDA requests that practitioners report to FDA any cases of suspected fungal or bacterial infections, which have occurred within the last six months, associated with drugs labeled as sterile from Franck’s Pharmacy.

For more information please visit: Franck's

Drug Safety and Availability > Updated: FDA Issues Second Warning to Physicians about Certain Compounded Drugs from Franck's